Business » Biotechnology and Pharmaceuticals	UPDATE INFO | REPORT BROKEN LINK
Novartis	Popularity:    Hit: 641

Details:

Created by the merger of Ciba and Sandoz. Has core businesses in healthcare, agribusiness and consumer health. URL: http://www.novartis.com/ Title: Novartis, an innovative healthcare products company with pharmaceutical treatments for heart disease, high blood pressure, diabetes, parkinsonOCOs, alzheimerOCOs, infectious disease and cancer. Image: Description: Business, Biotechnology and Pharmaceuticals - Novartis. Created by the merger of Ciba and Sandoz. Similar:

Related Sites

Benitec (Popularity: ): Offers gene silencing platform technology. Including description of RNA interference, resources page and details of commercial licensing opportunities. Bio Matera, Inc. (Popularity: ): Uses bacteria and agricultural products to produce biopolymers. Applications are for medical devices, anti-aging creams and food packaging. Explains the ... Biocon, Ltd. (Popularity: ): Produces industrial enzymes used to enhance food products, animal feed, detergents, leather, paper, starches, and textiles. Also, used for facilitating ... Biogemma (Popularity: ): Specializing in the development of new tools contributing to the improvement of the agronomic performance and end use quality of ... Biologics Process Development, Inc. (Popularity: ): Provides laboratory services in cell culture and protein purification and process development and scale-up. Biopract GmbH (Popularity: ): Microbial preparations, soil remediation and water depollution. BioSeek Inc. (Popularity: ): Develops high throughput biological systems for the validation and development of novel human therapeutics. BioUpdate.com (Popularity: ): Specializing in genomics and biotechnology research with particular experience in microarrays and instrumentation for high throughput molecular biology. Celera Genomics Group (Popularity: ): Mapped the human genome and develop new drugs based on their research. Features a range of corporate data, investor information, ... Chiron Corporation (Popularity: ): Participates in therapeutics, blood testing and vaccines. Conducts research and development in the fields of recombinant technology, gene therapy, vaccines, ... MWG Biotech (Popularity: ): Products and services include molecular biology instruments, DNA sequencing, oligos, microarrays, and bioinformatics. Novozymes.com (Popularity: ): Creates bio-industrial products by using enzymes for such things as waste water cleanup, house cleaners and lawn maintenance. Provides contact ...

Popular Sites

Global Pharmatech (Popularity: ): Manufacturer of liquid sterile parenterals, pharmaceutical formulation, small volume parenterals, large volume parenterals, sterile ear and eye drops, vitamin formulations, ... Scigenics Biotech (Popularity: ): Scigenics Biotech Pioneer in manufacture of ORBITEK range of Shakers,specifically addressed to the field of Life sciences and Biotechnology.Some of ... AirClean® Systems Canada (Popularity: ): AirClean® Systems Canada is a leading provider of activated bonded carbon filters, HEPA filters and more at very affordable rates. ... Pcd Pharma Company (Popularity: ): PCD in pharma means Propoganda cum Distribution. There are lot of Pharma companies involved in Pcd as their marketing strategy. ... Myramar Fuengirola Hotel (Popularity: ): Myramarhotels offers you a great selection of malaga hotels to enjoy costa del sol holidays. The best choice for apartments ...

Related Press

Novartis committed to making Galvus® available for patients with type 2 diabetes after US regulators issue "approvable letter" (Popularity: ): * Novartis confident in safety and efficacy of Galvus as a once-daily oral treatment for patients with type 2 diabetes, ... 4-Antibody AG Closes CHF 6 Million Series A Financing and Appoints Sijmen de Vries as CEO (Popularity: ): 4-Antibody, a Basel-based biotechnology company focused on exploiting its proprietary platform to develop de novo and improved fully human antibodies, ... Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 (Popularity: ): Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches ... Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ... FDA Approves Vaccines for the 2010-2011 Influenza Season (Popularity: ): The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the ...